Edwards Lifesciences Corp (NYSE:EW) Stock upgraded by BofA Securities
BofA Securities raised the price target for the Edwards Lifesciences Corp (NYSE:EW) stock from “a Neutral” to “a Buy”. The rating was released on March 07, 2024, according to finviz. The research report from Evercore ISI has downgraded the stock from Outperform to In-line, with a price target set at $77. In their research brief […]
Is price-to-earnings ratio of 40.75 for Edwards Lifesciences Corp (NYSE:EW) Stock digestible?
BofA Securities raised the price target for the Edwards Lifesciences Corp (NYSE:EW) stock from “a Neutral” to “a Buy”. The rating was released on March 07, 2024, according to finviz. The research report from Evercore ISI has downgraded the stock from Outperform to In-line, with a price target set at $77. In their research brief […]
